182 related articles for article (PubMed ID: 11518722)
21. [Role of heparan sulfate in axon guidance].
Inatani M
Seikagaku; 2011 Mar; 83(3):224-30. PubMed ID: 21516689
[No Abstract] [Full Text] [Related]
22. [From gene to disease; hereditary multiple exostoses].
Wuyts W; Bovée JV; Hogendoorn PC
Ned Tijdschr Geneeskd; 2002 Jan; 146(4):162-4. PubMed ID: 11845565
[TBL] [Abstract][Full Text] [Related]
23. Identification of a third EXT-like gene (EXTL3) belonging to the EXT gene family.
Van Hul W; Wuyts W; Hendrickx J; Speleman F; Wauters J; De Boulle K; Van Roy N; Bossuyt P; Willems PJ
Genomics; 1998 Jan; 47(2):230-7. PubMed ID: 9479495
[TBL] [Abstract][Full Text] [Related]
24. Reevaluation of a genetic model for the development of exostosis in hereditary multiple exostosis.
Hall CR; Cole WG; Haynes R; Hecht JT
Am J Med Genet; 2002 Sep; 112(1):1-5. PubMed ID: 12239711
[TBL] [Abstract][Full Text] [Related]
25. Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes.
Wuyts W; Van Hul W
Hum Mutat; 2000; 15(3):220-7. PubMed ID: 10679937
[TBL] [Abstract][Full Text] [Related]
26. The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate.
Lind T; Tufaro F; McCormick C; Lindahl U; Lidholt K
J Biol Chem; 1998 Oct; 273(41):26265-8. PubMed ID: 9756849
[TBL] [Abstract][Full Text] [Related]
27. A sugar fix for bone tumours?
Stickens D; Evans GA
Nat Genet; 1998 Jun; 19(2):110-1. PubMed ID: 9620760
[No Abstract] [Full Text] [Related]
28. rib-2, a Caenorhabditis elegans homolog of the human tumor suppressor EXT genes encodes a novel alpha1,4-N-acetylglucosaminyltransferase involved in the biosynthetic initiation and elongation of heparan sulfate.
Kitagawa H; Egusa N; Tamura JI; Kusche-Gullberg M; Lindahl U; Sugahara K
J Biol Chem; 2001 Feb; 276(7):4834-8. PubMed ID: 11121397
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells.
Ropero S; Setien F; Espada J; Fraga MF; Herranz M; Asp J; Benassi MS; Franchi A; Patiño A; Ward LS; Bovee J; Cigudosa JC; Wim W; Esteller M
Hum Mol Genet; 2004 Nov; 13(22):2753-65. PubMed ID: 15385438
[TBL] [Abstract][Full Text] [Related]
30. A novel EXT1 gene mutation causing hereditary multiple exostoses in a Chinese pedigree.
Li Y; Wang J; Li H; Wang J; Wang X; Fu Q
Pathology; 2010 Jan; 42(1):91-3. PubMed ID: 20025490
[No Abstract] [Full Text] [Related]
31. Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode alpha 1,4- N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/ heparin biosynthesis.
Kim BT; Kitagawa H; Tamura J; Saito T; Kusche-Gullberg M; Lindahl U; Sugahara K
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7176-81. PubMed ID: 11390981
[TBL] [Abstract][Full Text] [Related]
32. Heparan sulfate: lessons from knockout mice.
Forsberg E; Kjellén L
J Clin Invest; 2001 Jul; 108(2):175-80. PubMed ID: 11457868
[No Abstract] [Full Text] [Related]
33. Perichondrium phenotype and border function are regulated by Ext1 and heparan sulfate in developing long bones: a mechanism likely deranged in Hereditary Multiple Exostoses.
Huegel J; Mundy C; Sgariglia F; Nygren P; Billings PC; Yamaguchi Y; Koyama E; Pacifici M
Dev Biol; 2013 May; 377(1):100-12. PubMed ID: 23458899
[TBL] [Abstract][Full Text] [Related]
34. EXT1 regulates chondrocyte proliferation and differentiation during endochondral bone development.
Hilton MJ; Gutiérrez L; Martinez DA; Wells DE
Bone; 2005 Mar; 36(3):379-86. PubMed ID: 15777636
[TBL] [Abstract][Full Text] [Related]
35. Roles of heparan sulfate in mammalian brain development current views based on the findings from Ext1 conditional knockout studies.
Yamaguchi Y; Inatani M; Matsumoto Y; Ogawa J; Irie F
Prog Mol Biol Transl Sci; 2010; 93():133-52. PubMed ID: 20807644
[TBL] [Abstract][Full Text] [Related]
36. Association of autism in two patients with hereditary multiple exostoses caused by novel deletion mutations of EXT1.
Li H; Yamagata T; Mori M; Momoi MY
J Hum Genet; 2002; 47(5):262-5. PubMed ID: 12032595
[TBL] [Abstract][Full Text] [Related]
37. 20 novel point mutations and one large deletion in EXT1 and EXT2 genes: report of diagnostic screening in a large Italian cohort of patients affected by hereditary multiple exostosis.
Ciavarella M; Coco M; Baorda F; Stanziale P; Chetta M; Bisceglia L; Palumbo P; Bengala M; Raiteri P; Silengo M; Caldarini C; Facchini R; Lala R; Cavaliere ML; De Brasi D; Pasini B; Zelante L; Guarnieri V; D'Agruma L
Gene; 2013 Feb; 515(2):339-48. PubMed ID: 23262345
[TBL] [Abstract][Full Text] [Related]
38. [Denaturant gradient gel electrophoresis in the genetic diagnosis of hereditary multiple exostoses].
He HB; Hu ZM; Li HJ; Zhu Y; Shi XL; Lei GH; Zhou JN; Li KH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):323-7. PubMed ID: 17478946
[TBL] [Abstract][Full Text] [Related]
39. A novel deletion mutation of the EXT2 gene in a large Chinese pedigree with hereditary multiple exostosis.
Xiao CY; Wang J; Zhang SZ; Van Hul W; Wuyts W; Qiu WM; Wu H; Zhang G
Br J Cancer; 2001 Jul; 85(2):176-81. PubMed ID: 11461073
[TBL] [Abstract][Full Text] [Related]
40. [Proteoglycan core glycosyltransferases].
Uyama T; Kitagawa H; Sugahara K
Tanpakushitsu Kakusan Koso; 2003 Jun; 48(8 Suppl):1019-26. PubMed ID: 12807004
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
